CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shanghai ZJ Bio-Tech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shanghai ZJ Bio-Tech Co Ltd
Building 26
No.588 Xinjun Ring Road, Pujiang Hi-Tech
Phone: +86 2134635507p:+86 2134635507 SHANGHAI, SHA  201114  China Ticker: 688317688317
Business Summary
Shanghai ZJ Bio-Tech Co Ltd is a China-based company primarily engaged in the research and development, production, and sales of molecular diagnostic reagents and instrument equipment. The Company’s main products are nucleic acid testing kits and molecular diagnostic instruments. The Company’s products are applied in areas such as public health emergencies, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The Company distributes its products within the domestic market and to overseas markets.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JunbinShao 51 2/1/2021 2/1/2021
Chief Financial Officer, Deputy General Manager, Secretary of the Board, Director WeiqinNi 41 12/1/2021 12/1/2021
General Manager LiliangLu 45 2/1/2021 2/1/2021
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 285 (As of 12/31/2024)
Outstanding Shares: 192,157,999 (As of 9/30/2025)
Shareholders: 16,475
Stock Exchange: SHA
Fax Number: +86 2134635507


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 3, 2026